WallStreetZenWallStreetZen

NASDAQ: ALZN
Alzamend Neuro Inc Stock

$0.63-0.02 (-3.08%)
Updated May 17, 2024
ALZN Price
$0.63
Fair Value Price
$0.79
Market Cap
$4.35M
52 Week Low
$0.44
52 Week High
$11.91
P/E
-0.34x
P/B
-1.02x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$12.40M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.07
Operating Cash Flow
-$9M
Beta
1.04
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ALZN Overview

Alzamend Neuro, Inc., is a clinical-stage biopharmaceutical company developing products to treat neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its pipeline includes AL001 for the treatment of Alzheimer's, other neurodegenerative diseases, and psychiatric disorders, and AL002, to restore patients' immunological systems to combat Alzheimer's. The company was founded in 2016 and is headquartered in Tampa, FL.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ALZN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ALZN ($0.63) is undervalued by 19.82% relative to our estimate of its Fair Value price of $0.79 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ALZN ($0.63) is not significantly undervalued (19.82%) relative to our estimate of its Fair Value price of $0.79 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ALZN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ALZN due diligence checks available for Premium users.

Be the first to know about important ALZN news, forecast changes, insider trades & much more!

ALZN News

Valuation

ALZN fair value

Fair Value of ALZN stock based on Discounted Cash Flow (DCF)
Price
$0.63
Fair Value
$0.79
Undervalued by
20.33%
ALZN ($0.63) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ALZN ($0.63) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ALZN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ALZN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.34x
Industry
8.47x
Market
30.97x

ALZN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-1.02x
Industry
6.01x

ALZN's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.7M
Profit Margin
0%
ALZN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$782.6k
Liabilities
$4.6M
Debt to equity
-1.07
ALZN's short-term liabilities ($3.83M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ALZN's long-term liabilities ($742.26k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ALZN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ALZN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.0M
Investing
$0.0
Financing
$2.1M
ALZN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ALZN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ALZN$4.35M-2.31%-0.34x-1.02x
GTBP$4.42M-4.59%-0.45x0.83x
XCUR$4.28M-4.62%0.23x0.95x
FRES$4.27M+13.64%-0.14x0.33x
THAR$4.26M-1.90%-0.15x0.60x

Alzamend Neuro Stock FAQ

What is Alzamend Neuro's quote symbol?

(NASDAQ: ALZN) Alzamend Neuro trades on the NASDAQ under the ticker symbol ALZN. Alzamend Neuro stock quotes can also be displayed as NASDAQ: ALZN.

If you're new to stock investing, here's how to buy Alzamend Neuro stock.

What is the 52 week high and low for Alzamend Neuro (NASDAQ: ALZN)?

(NASDAQ: ALZN) Alzamend Neuro's 52-week high was $11.91, and its 52-week low was $0.44. It is currently -94.68% from its 52-week high and 44.42% from its 52-week low.

How much is Alzamend Neuro stock worth today?

(NASDAQ: ALZN) Alzamend Neuro currently has 6,866,846 outstanding shares. With Alzamend Neuro stock trading at $0.63 per share, the total value of Alzamend Neuro stock (market capitalization) is $4.35M.

Alzamend Neuro stock was originally listed at a price of $202.50 in Jun 15, 2021. If you had invested in Alzamend Neuro stock at $202.50, your return over the last 2 years would have been -99.69%, for an annualized return of -94.4% (not including any dividends or dividend reinvestments).

How much is Alzamend Neuro's stock price per share?

(NASDAQ: ALZN) Alzamend Neuro stock price per share is $0.63 today (as of May 17, 2024).

What is Alzamend Neuro's Market Cap?

(NASDAQ: ALZN) Alzamend Neuro's market cap is $4.35M, as of May 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Alzamend Neuro's market cap is calculated by multiplying ALZN's current stock price of $0.63 by ALZN's total outstanding shares of 6,866,846.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.